“…Historically, PEMFs have been used in a clinical setting to treat delayed unions of bone fractures (Becker, Spadaro, & Marino, 1977). More recently, clinical studies of PEMFs have shown improvements in subjective measures of clinical function and pain following anterior cruciate ligament (ACL) reconstruction, bone marrow–derived stem cell transplantation, matrix‐assisted chondrocyte implantation (MACI®), microfracture, and chondroabrasion (Benazzo, Zanon, et al, 2008; Cadossi et al, 2014; Collarile, Sambri, Lullini, Cadossi, & Zorzi, 2018; Osti, Del Buono, & Maffulli, 2015; Zorzi, Dall'Oca, Cadossi, & Setti, 2007). However, while these initial clinical studies were promising, additional preclinical and mechanistic studies are required to support or oppose the regular use of PEMFs as an adjuvant strategy for cartilage repair rather than as a pain management tool (American Academy of Orthopaedic Surgeons Board of Directors, 2013; Bjordal et al, 2007; Gobbi, Lad, Petrera, & Karnatzikos, 2014).…”